{
  "meta": {
    "title": "Biochemistry_Subject_Test_2_Proteins_Amino_Acids_Carbohydrates",
    "url": "https://brainandscalpel.vercel.app/biochemistry-subject-test-2-proteins-amino-acids-carbohydrates-c132613d.html",
    "scrapedAt": "2025-11-30T11:10:40.199Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Homogentisic Acid</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylpyruvic Acid</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man presents with progressive darkening of his ears and sclerae. On examination, you note bluish-black discoloration of the cartilages of the ears and the ocular sclerae. His urine sample, when left standing, turns dark brown-black. Radiographs of the spine reveal dense calcification and degeneration of the intervertebral discs. This clinical presentation is most directly a consequence of the accumulation of which of the following metabolites?</span></p>",
      "unique_key": "Q319488",
      "question_audio": null,
      "question_video": null,
      "map_id": 319488,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical scenario described is a classic presentation of <strong>Alkaptonuria</strong>, an autosomal recessive disorder.</p><p><strong>Defective Enzyme &amp; Biochemical Pathway:</strong></p><ul><li>Alkaptonuria is caused by a <strong>deficiency of the enzyme homogentisate 1,2-dioxygenase</strong> (also known as homogentisic acid oxidase).</li><li>This enzyme is crucial in the catabolic pathway of the aromatic amino acids <strong>phenylalanine and tyrosine</strong>.</li><li>The specific metabolic block occurs at the step where homogentisic acid is normally converted to <strong>maleylacetoacetate</strong>.</li></ul><p><strong>Accumulation of the Metabolite:</strong></p><ul><li>Due to the enzyme deficiency, <strong>homogentisic acid</strong> cannot be metabolized further and accumulates in the body.</li><li>The accumulated homogentisic acid has two main fates, which explain the clinical signs:<ul><li><strong>Excretion in Urine:</strong><ul><li>Excess homogentisic acid is excreted in the urine.</li><li>Upon standing, it gets oxidized by atmospheric oxygen to a <strong>dark brown-black pigment</strong> (alkapton), leading to the characteristic darkening of urine.</li></ul></li><li><strong>Deposition in Tissues:</strong><ul><li>Homogentisic acid polymers are deposited in connective tissues, a condition known as <strong>ochronosis</strong>.</li><li>This deposition is responsible for the bluish-black discoloration of the ears, sclerae, and other cartilaginous structures.</li></ul></li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/1E.png\"><p><strong>Pathogenesis of Clinical Features:</strong></p><ul><li><strong>Ochronosis:</strong> The deposited polymerized homogentisic acid pigment binds irreversibly to collagen in cartilage, tendons, and skin, causing the distinctive dark pigmentation and making the tissues brittle.</li><li><strong>Arthropathy:</strong> The brittleness of the ochronotic cartilage leads to its degeneration, particularly in the spine and large joints. This explains the radiographic findings of dense calcification and disc degeneration, which are hallmark features of the disease.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Phenylalanine (Option A):</strong></p><ul><li>Accumulation of phenylalanine is seen in <strong>Phenylketonuria (PKU)</strong>, due to a deficiency of phenylalanine hydroxylase.</li><li>PKU presents with intellectual disability, seizures, and musty body odor, not the connective tissue findings described.</li></ul><p><strong>Phenylpyruvic Acid (Option C):</strong></p><ul><li>This is a derivative of phenylalanine that accumulates in PKU, not in Alkaptonuria.</li><li>It is detected in the urine of PKU patients using ferric chloride test.</li></ul><p><strong>Melanin (Option D):</strong></p><ul><li>Increased melanin production is seen in various conditions like Addison's disease, but it does not cause urine darkening or the specific arthropathy seen in this case.</li><li>The pigment in Alkaptonuria is <em>not</em> melanin but an oxidation product of homogentisic acid.</li></ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Alanine Aminotransferase (ALT)</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate Dehydrogenase (GDH)</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspartate Aminotransferase (AST)</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutaminase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the catabolism of amino acids, the primary reaction that liberates free ammonia for entry into the urea cycle is the oxidative deamination of glutamate. Which of the following enzymes catalyzes this central reaction?</span></p>",
      "unique_key": "Q319489",
      "question_audio": null,
      "question_video": null,
      "map_id": 319489,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Role of the Enzyme:</strong></p><ul><li><strong>Glutamate Dehydrogenase (GDH)</strong> is the primary enzyme responsible for <strong>oxidative deamination in</strong> mammalian tissues.</li><li>It catalyzes the following reaction: <strong>L-Glutamate + NAD&#8314; + H&#8322;O &#8594; &alpha;-Ketoglutarate + NADH + H&#8314; + NH<sub>3</sub></strong>.</li><li>This reaction directly produces free <strong>ammonia (NH<sub>3</sub>)</strong>, which is the substrate for the urea cycle.</li></ul><p><strong>Central Role in Nitrogen Metabolism:</strong></p><ul><li>Amino groups from most amino acids are first transferred to &alpha;-ketoglutarate via transamination, forming <strong>glutamate</strong>.</li><li>GDH then acts on this pooled glutamate, functioning as a major \"funnel\" that releases nitrogen as ammonia for disposal.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/2E.png\"><p><strong>Explanation for Incorrect options:</strong></p><p><strong>ALT (Option A) &amp; AST (Option C):</strong></p><ul><li>These are <strong>transaminases</strong>.</li><li>They transfer amino groups between amino acids and keto acids but <strong>do not release free ammonia</strong>.</li></ul><p><strong>Glutaminase (Option D):</strong></p><ul><li>This enzyme hydrolyzes glutamine to glutamate and ammonia. While it produces ammonia, its role is more specific (e.g., in the kidney).</li><li><strong>GDH is the central enzyme for oxidative deamination</strong> of amino acids collected as glutamate</li></ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystine</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Cysteine</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Methionine</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Homocysteine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-year-old child is brought to the pediatrician with failure to thrive, vitamin D-resistant rickets, and photophobia due to corneal crystals. Urinalysis reveals glycosuria, aminoaciduria, and phosphaturia. The underlying molecular defect in this condition is best described as a deficiency in a specific lysosomal transporter for which of the following amino acids?</span></p>",
      "unique_key": "Q319490",
      "question_audio": null,
      "question_video": null,
      "map_id": 319490,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical presentation is classic for <strong>Nephropathic Cystinosis</strong>, an autosomal recessive lysosomal storage disorder.</p><p><strong>Defective Protein &amp; Pathophysiology:</strong></p><ul><li>Cystinosis is caused by a defect in the <strong>cystinosin protein</strong>.</li><li>Cystinosin is a <strong>lysosomal membrane transporter</strong>.</li><li>Its specific function is to transport the amino acid <strong>cystine</strong> (the oxidized dimer of cysteine) <strong>out of the lysosome</strong> into the cytosol.</li><li>A defect in this transporter leads to the massive accumulation of <strong>free cystine within the lysosomes</strong> of various cells throughout the body.</li></ul><p><strong>Consequence of Accumulation:</strong></p><ul><li>The accumulated cystine forms <strong>crystals</strong> within the lysosomes, which disrupts cellular function.</li><li>Cells particularly affected are those in the <strong>kidneys (proximal tubular cells), cornea, bone marrow, and thyroid gland</strong>.</li></ul><p><strong>Correlation of Clinical Features with Biochemistry:</strong></p><ul><li><strong>Renal Fanconi Syndrome (Polyuria, Polydipsia, Acidosis, Hypokalemia, Phosphaturia):</strong><ul><li>This is the hallmark of infantile nephropathic cystinosis.</li><li>Cystine crystal accumulation damages the proximal renal tubules, impairing reabsorption of water, glucose, phosphate, amino acids, and electrolytes.</li><li>This leads to the characteristic findings of failure to thrive, polyuria, and metabolic abnormalities.</li></ul></li><li><strong>Corneal Cystine Crystals:</strong> The deposition of cystine crystals in the cornea is pathognomonic and is easily detected by slit-lamp examination. It can cause photophobia.</li><li><strong>Failure to Thrive:</strong> Results from a combination of chronic dehydration, electrolyte losses, and metabolic acidosis due to renal tubular dysfunction. </li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/3E.png\"><p><strong>Explanation for Incorrect options:</strong></p><ul><li><strong>Cysteine (Option B):</strong> The defect is specific for <strong>cystine</strong> Cysteine is the reduced monomeric form, soluble and not the stored metabolite in cystinosis.</li><li><strong>Methionine (Option C):</strong> Defects in methionine metabolism cause <strong>homocystinuria</strong>, not cystinosis. Presents with marfanoid habitus, ectopia lentis, and thromboembolism.</li><li><strong>Homocysteine (Option D):</strong> Elevated in homocystinuria due to cystathionine &beta;-synthase deficiency. Features intellectual disability, lens dislocation, vascular events - not renal Fanconi syndrome with corneal crystals.</li></ul>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">D-Amino Acid Oxidase</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Flavin-containing monooxygenase 3 (FMO3)</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystathionine &beta;-synthase</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine Hydroxylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old female presents to the dermatology clinic with a persistent, offensive body odour reminiscent of rotting fish. She reports that the symptom has been present since childhood and is exacerbated after consuming eggs, seafood, and legumes. Physical examination is unremarkable except for the characteristic odour. Urinalysis is significant for a strong fishy smell. This condition is most likely due to a deficiency of which of the following enzymes?</span></p>",
      "unique_key": "Q319491",
      "question_audio": null,
      "question_video": null,
      "map_id": 319491,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical scenario described is a classic presentation of <strong>Trimethylaminuria</strong>, also known as <strong>Fish Odour Syndrome</strong>.</p><p><strong>Defective Enzyme &amp; Biochemical Pathway:</strong></p><ul><li>Trimethylaminuria is caused by a <strong>deficiency in the enzyme Flavin-containing monooxygenase 3 (FMO3)</strong>.</li><li>This enzyme is predominantly expressed in the <strong>liver</strong> and is a crucial component of the <strong>microsomal cytochrome P450 monooxygenase system</strong>.</li><li>Its primary role in this context is the <strong>N-oxidation of trimethylamine (TMA)</strong>.</li></ul><p><strong>Source and Metabolism of the Odorous Compound:</strong></p><ul><li><strong>Dietary Precursors:</strong> Foods rich in <strong>choline</strong> (eggs, liver), <strong>lecithin</strong> (legumes, soybeans), and <strong>trimethylamine N-oxide (TMAO)</strong> (seafood, saltwater fish) are the source.</li><li><strong>Gut Bacteria:</strong> Intestinal bacteria metabolize these dietary compounds to produce <strong>Trimethylamine (TMA)</strong>, a volatile, foul-smelling amine with a strong fishy odour.</li><li><strong>Normal Detoxification:</strong> Normally, TMA is absorbed from the gut and transported to the liver, where <strong>FMO3</strong> converts it to <strong>non-odorous trimethylamine N-oxide (TMAO)</strong>, which is then excreted in urine.</li><li><strong>Defect in Disease:</strong> In FMO3 deficiency, this conversion is impaired. As a result, large amounts of <strong>unmetabolized TMA</strong> It is excreted in <strong>urine, sweat, and breath</strong>, causing the characteristic offensive body odour.</li></ul><p><strong>Correlation of Clinical Features:</strong></p><ul><li><strong>Offensive Body Odour:</strong> Directly due to excretion of volatile TMA.</li><li><strong>Exacerbation by Specific Foods:</strong> Consumption of choline, lecithin, or TMAO-rich foods provides more substrate (TMA), overwhelming the limited enzyme activity and worsening the symptoms.</li><li><strong>Presentation from Childhood:</strong> This is an inherited autosomal recessive disorder, so symptoms typically manifest early in life.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>D-Amino Acid Oxidase (Option A):</strong> This enzyme oxidizes D-amino acids (which are rare in humans) to their corresponding &alpha;-keto acids. Its deficiency is not associated with any known clinical syndrome, and certainly not with a fish-like body odour.</p><p><strong>Cystathionine &beta;-synthase (Option C):</strong> A deficiency of this enzyme causes <strong>Homocystinuria</strong>, which presents with marfanoid habitus, intellectual disability, ectopia lentis, and thromboembolic events, not a body odour.</p><p><strong>Phenylalanine Hydroxylase (Option D):</strong> A deficiency of this enzyme causes <strong>Phenylketonuria (PKU)</strong>, which presents with musty/mousy odour (due to phenylacetate accumulation), intellectual disability, seizures, and fair skin. The odour is distinct from that of rotting fish.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Acidic Amino Acid</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Basic Amino Acid</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Neutral Amino Acid, Non-polar</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Neutral Amino Acid, Polar</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A researcher is studying the properties of amino acids. He isolates an amino acid that has a single methyl group as its side chain and is characterized by having no charge on its side chain at physiological pH. This amino acid is most likely to be classified under which of the following categories?</span></p>",
      "unique_key": "Q319492",
      "question_audio": null,
      "question_video": null,
      "map_id": 319492,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The question describes the amino acid <strong>Alanine</strong>.</p><p><strong>Classification of Amino Acids:</strong></p><p>Amino acids are primarily classified based on the properties of their <strong>side chains (R groups)</strong> at physiological pH (7.4). The two main criteria are:</p><ul><li><strong>Presence of Charge:</strong> Acidic (negative charge), Basic (positive charge), or Neutral (no charge).</li><li><strong>Polarity:</strong> Polar (hydrophilic) or Non-polar (hydrophobic).</li></ul><p><strong>Analyzing the Description:</strong></p><ul><li><strong>\"No charge on its side chain at physiological pH\":</strong> This immediately rules out Acidic and Basic amino acids, which have charged side chains. It confirms the amino acid is <strong>Neutral</strong>.</li><li><strong>\"A single methyl group as its side chain\":</strong> The side chain (-CH<sub>3</sub>) is a simple hydrocarbon. It is <strong>non-polar</strong> and <strong>hydrophobic</strong> because it lacks atoms that can participate in hydrogen bonding or have electronegativity differences to create polarity.</li></ul><p><strong>Conclusion:</strong></p><p>An amino acid with an aliphatic, non-polar, hydrophobic side chain and no charge is classified as a <strong>Neutral, Non-polar Amino Acid</strong>.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/5E.png\"><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Acidic Amino Acid (Option A):</strong> These have side chains containing a carboxyl group (e.g., Aspartate, Glutamate) that carries a <strong>negative charge</strong> at pH 7.4.</p><p><strong>Basic Amino Acid (Option B):</strong> These have side chains containing an amino group (e.g., Lysine, Arginine, Histidine) that carries a <strong>positive charge</strong> at pH 7.4.</p><p><strong>Neutral Amino Acid, Polar (Option D):</strong> These have side chains that are uncharged but contain polar functional groups like hydroxyl (-OH) in Serine/Threonine, sulfhydryl (-SH) in Cysteine, or amide groups (in Asparagine/Glutamine) that make them hydrophilic. A methyl group is not polar.</p><p><strong>Key Takeaways:</strong></p><p>It is crucial to remember that the category \"Neutral Amino Acids\" is subdivided based on polarity:</p><ol><li><strong>Neutral, Non-polar (Hydrophobic):</strong><ol><li><strong>Examples:</strong> Glycine, Alanine, Valine, Leucine, Isoleucine, Proline, Methionine, Tryptophan, Phenylalanine.</li><li><strong>Property:</strong> Hydrophobic side chains that tend to be buried inside protein structures.</li></ol></li><li><strong>Neutral, Polar (Hydrophilic, Uncharged):</strong><ol><li><strong>Examples:</strong> Serine, Threonine, Cysteine, Asparagine, Glutamine, Tyrosine.</li><li><strong>Property:</strong> Side chains can form hydrogen bonds with water, making them hydrophilic. They are often found on the surface of proteins.</li></ol></li></ol>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridoxal Phosphate</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetrahydrobiopterin (BH4)</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylcobalamin</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetrahydrofolate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An infant with hyperphenylalaninemia shows no neurological improvement on a phenylalanine-restricted diet. Further workup reveals deficient synthesis of neurotransmitters like dopamine and serotonin. This condition is most specifically due to a deficiency of which cofactor?</span></p>",
      "unique_key": "Q319493",
      "question_audio": null,
      "question_video": null,
      "map_id": 319493,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>This clinical picture is characteristic of <strong>Biopterin deficiency</strong>, also known as <strong>Malignant or Atypical Phenylketonuria (PKU)</strong>.</p><p><strong>Central Role of Tetrahydrobiopterin (BH4):</strong></p><ul><li>BH4 is not just a cofactor for one enzyme; it is <strong>essential for the activity of three key aromatic amino acid hydroxylases</strong>:<ul><li><strong>Phenylalanine Hydroxylase (PAH):</strong> Converts phenylalanine to tyrosine.</li><li><strong>Tyrosine Hydroxylase:</strong> The rate-limiting enzyme in the synthesis of catecholamines (Dopamine, Norepinephrine).</li><li><strong>Tryptophan Hydroxylase:</strong> The rate-limiting enzyme in the synthesis of Serotonin (5-HT).</li></ul></li></ul><p><strong>Consequences of BH4 Deficiency:</strong></p><ul><li>The deficiency creates a <strong>dual metabolic block</strong>:<ul><li><strong>Block 1: Hyperphenylalaninemia.</strong> Without BH4, PAH cannot function, leading to the accumulation of phenylalanine. This is the initial laboratory finding.</li><li><strong>Block 2: Neurotransmitter Deficiency.</strong> Crucially, the synthesis of the critical neurotransmitters <strong>dopamine and serotonin</strong> is also halted due to the failure of Tyrosine and Tryptophan hydroxylases. This is the root cause of the severe, progressive neurological symptoms.</li></ul></li></ul><p><strong>Clinical Scenario:</strong></p><ul><li>The lack of improvement with a phenylalanine-restricted diet is a key diagnostic clue.</li><li>The diet addresses the hyperphenylalaninemia (Block 1) but does nothing to correct the underlying neurotransmitter deficiency (Block 2), which is the primary driver of the neurological decline.</li><li>The deficient levels of neurotransmitter metabolites confirm the impaired synthesis of dopamine and serotonin within the central nervous system.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Pyridoxal Phosphate (Vitamin B6) (Option A):</strong> This is a cofactor for decarboxylase enzymes (e.g., Aromatic L-amino acid decarboxylase) that are involved <em>after</em> the hydroxylase steps. While its deficiency can cause seizures, it does not cause hyperphenylalaninemia.</p><p><strong>Methylcobalamin (Vitamin B12) (Option C):</strong> This cofactor is involved in the methionine synthase reaction for homocysteine remethylation. Its deficiency leads to megaloblastic anemia and subacute combined degeneration of the cord, not hyperphenylalaninemia.</p><p><strong>Tetrahydrofolate (THF) (Option D):</strong> Like B12, folate is central to one-carbon metabolism and nucleotide synthesis. Its deficiency causes megaloblastic anemia and is linked to neural tube defects, but not to this specific combination of findings.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Lysosome</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Calpain complex</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">26S Proteasome</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Caspase enzyme system</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient with multiple myeloma is started on a chemotherapeutic agent that selectively inhibits a specific intracellular complex. This complex is a large, barrel-shaped structure with a central cavity responsible for the ATP-dependent degradation of ubiquitin-tagged proteins, particularly regulatory proteins and misfolded proteins. The therapeutic agent acts by inhibiting which of the following cellular components?</span></p>",
      "unique_key": "Q319494",
      "question_audio": null,
      "question_video": null,
      "map_id": 319494,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The question describes the mechanism of a class of drugs called <strong>Proteasome Inhibitors</strong> (e.g., Bortezomib, Carfilzomib), which are a cornerstone of treatment for multiple myeloma.</p><p><strong>Structure and Function of the 26S Proteasome:</strong></p><ul><li>The <strong>26S proteasome</strong> is a large, multi-subunit, <strong>barrel-shaped protein complex</strong> present in the cytosol and nucleus of all eukaryotic cells.</li><li>Its primary function is <strong>ATP-dependent degradation of intracellular proteins</strong>.</li><li>It acts as the catalytic core of the <strong>Ubiquitin-Proteasome Pathway (UPP)</strong>, which is the major non-lysosomal mechanism for controlled protein breakdown.</li></ul><p><strong>Specificity of Degradation:</strong></p><ul><li>Proteins destined for degradation by the proteasome are first tagged by the covalent attachment of a chain of <strong>ubiquitin</strong> molecules (polyubiquitination).</li><li>The proteasome specifically recognizes and unfolds these <strong>ubiquitin-tagged proteins</strong>.</li><li>Its targets include:<ul><li><strong>Short-lived regulatory proteins</strong> (e.g., cyclins, transcription factors like NF-&kappa;B, tumor suppressor p53).</li><li><strong>Misfolded, denatured, or damaged proteins.</strong></li></ul></li></ul><p><strong>Clinical Correlation in Multiple Myeloma:</strong></p><ul><li>Plasma cells in multiple myeloma are prolific producers of immunoglobulins, making them highly dependent on the proteasome to degrade misfolded proteins that accumulate during this rapid synthesis.</li><li>Inhibiting the <strong>26S proteasome</strong> (e.g., with Bortezomib) leads to an accumulation of pro-apoptotic proteins and cell cycle regulators within the malignant plasma cells, ultimately triggering <strong>apoptosis (programmed cell death)</strong> and controlling the disease.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Lysosome (Option A):</strong> Lysosomes degrade extracellular proteins (endocytosed) and intracellular organelles (autophagy) via <strong>acid hydrolases</strong>. Their degradation is <strong>not ATP-dependent</strong> in the same direct manner and does not require prior ubiquitination. They are not the primary target of drugs like Bortezomib.</p><p><strong>Calpain complex (Option B):</strong> Calpains are a family of <strong>calcium-dependent cysteine proteases</strong>. They are involved in limited proteolysis for signal transduction and in pathological conditions like ischemia, but they are not large, organized complexes for bulk protein degradation like the proteasome.</p><p><strong>Caspase enzyme system (Option D):</strong> Caspases are cysteine proteases that are key executioners of <strong>apoptosis</strong>. They cleave specific cellular substrates to dismantle the cell in an orderly fashion. They do not generally degrade ubiquitin-tagged proteins and are not barrel-shaped complexes.</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Ehlers-Danlos Syndrome</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Alport Syndrome</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteogenesis Imperfecta</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Epidermolysis Bullosa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A newborn baby presents with multiple fractures and severe bone deformities. Radiographic examination reveals poorly mineralized bones. A skin biopsy is performed for biochemical analysis, which reveals a genetic defect affecting the structure of type I collagen. This clinical presentation is most consistent with which of the following conditions?</span></p>",
      "unique_key": "Q319495",
      "question_audio": null,
      "question_video": null,
      "map_id": 319495,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The scenario describes a classic presentation of <strong>Osteogenesis Imperfecta (OI)</strong>, also known as \"brittle bone disease.\"</p><p><strong>Role of Type I Collagen:</strong></p><ul><li><strong>Type I collagen</strong> is the most abundant collagen in the human body.</li><li>It is the <strong>primary organic constituent of bone matrix</strong>, providing the tensile strength framework upon which mineralization occurs.</li><li>It is also a major component of <strong>skin, tendons, ligaments, and dentin</strong>.</li></ul><p><strong>Pathophysiology of Osteogenesis Imperfecta:</strong></p><ul><li>OI is predominantly caused by <strong>mutations in the genes encoding the pro-&alpha;1(I) or pro-&alpha;2(I) chains</strong> of type I collagen.</li><li>These mutations lead to the synthesis of <strong>structurally defective type I collagen</strong> or a significant reduction in its production.</li><li>The defective collagen matrix in bones results in:<ul><li><strong>Extreme bone fragility</strong> leading to multiple fractures with minimal trauma.</li><li><strong>Poor mineralization</strong> because the defective collagen scaffold cannot support normal hydroxyapatite crystal deposition.</li><li><strong>Bone deformities</strong> (e.g., bowing of long bones).</li></ul></li></ul><p><strong>Clinical Correlation:</strong></p><ul><li>The findings of <strong>fractures in a newborn</strong> and <strong>poorly mineralized bones on X-ray</strong> are hallmark features of severe, congenital forms of Osteogenesis Imperfecta.</li><li>The confirmatory clue is the <strong>defect in type I collagen</strong> identified on biochemical analysis.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Ehlers-Danlos Syndrome (EDS) (Option A):</strong> While EDS is also a disorder of collagen, it most commonly involves <strong>Type III collagen</strong> (vascular type) or Type V collagen (classical type). EDS primarily affects the skin (hyperextensibility) and joints (hypermobility), not primarily causing bone fragility and fractures.</p><p><strong>Alport Syndrome (Option B):</strong> This is a genetic disorder affecting <strong>Type IV collagen</strong>, which is a major component of the basement membrane in the <strong>kidnes (glomeruli), ears (cochlea), and eyes</strong>. It presents with progressive nephritis, sensorineural hearing loss, and ocular abnormalities, not bone fractures.</p><p><strong>Epidermolysis Bullosa (Option D):</strong> This is a group of disorders characterized by skin fragility and blistering. It is caused by mutations in proteins involved in dermal-epidermal adhesion (e.g., keratins, laminin, collagen VII), <strong>not type I collagen</strong>. Collagen VII defects are seen in Dystrophic Epidermolysis Bullosa.</p><p><strong>Key Takeaways:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/8E.png\">",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">CH2 and CH3 domains</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">VL and CL domains</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">VH and CH1 domains</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Variable Heavy (VH) and Variable Light (VL) domains</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A research student is studying the structure of immunoglobulin G (IgG) under an electron microscope. The basic monomeric unit of the antibody appears as a \"Y-shaped\" molecule. The region of the antibody that binds to a specific antigen is formed by the interaction between the variable domains of its constituent polypeptide chains. Which of the following domains directly interacts to form the antigen-binding site?</span></p>",
      "unique_key": "Q319496",
      "question_audio": null,
      "question_video": null,
      "map_id": 319496,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The antigen-binding site, also known as the <strong>paratope</strong>, is a highly specific pocket formed by the variable regions of the antibody.</p><p><strong>Basic Structure of an Immunoglobulin Monomer:</strong></p><ul><li>The basic \"Y-shaped\" unit of an antibody (e.g., IgG) is composed of <strong>four polypeptide chains</strong>: two identical <strong>Heavy (H) chains</strong> and two identical <strong>Light (L) chains</strong>.</li><li>These chains are held together by <strong>disulfide bonds</strong> and non-covalent interactions.</li><li>Each chain is divided into <strong>domains</strong> based on their amino acid sequence variability and function.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/9E.png\"><p><strong>Domain Organization:</strong></p><ul><li><strong>Light Chain:</strong> Has two domains - one <strong>Variable (VL)</strong> and one <strong>Constant (CL)</strong>.</li><li><strong>Heavy Chain:</strong> Has one <strong>Variable (VH)</strong> domain and three or four <strong>Constant (CH1, CH2, CH3, CH4) domains</strong>, depending on the antibody class.</li></ul><p><strong>Formation of the Antigen-Binding Site:</strong></p><ul><li>The <strong>Variable (V) domains</strong> of both the heavy and light chains have extreme variability in their amino acid sequences. This is the basis for the immense diversity of antibodies.</li><li>The <strong>Variable domain of the Heavy chain (VH)</strong> and the <strong>Variable domain of the Light chain (VL)</strong>come together at the tips of the \"Y\" arms (<strong>Fab fragment</strong>) to form a single, combined <strong>antigen-binding site</strong>.</li><li>The hypervariable regions within these VH and VL domains, also called <strong>Complementarity-Determining Regions (CDRs)</strong>, are the actual residues that make physical contact with the antigen.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>CH2 and CH3 domains (Option A):</strong> These are <strong>Constant domains</strong> of the Heavy chain. They form the <strong>Fc fragment</strong> (crystallizable fragment) of the antibody. The Fc region is responsible for effector functions like complement activation and binding to Fc receptors on phagocytic cells. It does not participate in antigen binding.</p><p><strong>VL and CL domains (Option B):</strong> While VL is correct, CL is a <strong>Constant domain</strong> of the Light chain. The CL domain pairs with the CH1 domain to provide structural stability to the Fab arm but does not contribute to the antigen-binding specificity.</p><p><strong>VH and CH1 domains (Option C):</strong> While VH is correct, CH1 is the first <strong>Constant domain</strong> of the Heavy chain. Like the CL domain, it provides structural support but is not part of the variable antigen-binding pocket.</p><p><strong>Key Takeaways:</strong></p><p><strong>Fab Fragment (Antigen-Binding Fragment):</strong> Generated by papain cleavage. Contains one <strong>antigen-binding site</strong> formed by <strong>VH + VL</strong>. Also includes the <strong>CH1 and CL domains</strong>.</p><p><strong>Fc Fragment (Crystallizable Fragment):</strong> Generated by papain cleavage. Contains the <strong>CH2 and CH3 domains</strong> and mediates effector functions.</p><p><strong>F(ab')2 Fragment:</strong> Generated by pepsin cleavage. Contains <strong>two antigen-binding sites</strong> and can still cross-link antigens.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">High solubility and rapid clearance</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Protease resistance and tissue insolubility</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased antigenicity and immune activation</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Enhanced enzymatic activity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old patient presents with progressive renal failure, macroglossia, and peripheral neuropathy. A biopsy of the abdominal fat pad shows positive staining with Congo red dye, exhibiting an apple-green birefringence under polarized light. The material deposited in the tissues in this condition has a characteristic &beta;-pleated sheet conformation. This conformation is responsible for which of the following properties of the deposited material?</span></p>",
      "unique_key": "Q319497",
      "question_audio": null,
      "question_video": null,
      "map_id": 319497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical presentation and biopsy findings are classic for <strong>AL Amyloidosis</strong> (Primary Amyloidosis), often associated with plasma cell dyscrasias.</p><p><strong>Nature of Amyloid Fibrils:</strong></p><ul><li>Amyloidosis is characterized by the extracellular deposition of insoluble, fibrous protein aggregates known as <strong>amyloid fibrils</strong>.</li><li>The defining structural feature of all amyloid fibrils is a <strong>cross &beta;-pleated sheet conformation</strong>. This is a non-physiological, stable protein conformation.</li></ul><p><strong>Consequences of the &beta;-Pleated Sheet Structure:</strong></p><ul><li><strong>Protease Resistance:</strong> The highly ordered, tightly packed, hydrogen-bonded structure of the &beta;-pleated sheet makes the amyloid fibrils <strong>highly resistant to degradation by proteases</strong>. Normal cellular mechanisms cannot clear these deposits.</li><li><strong>Tissue Insolubility:</strong> The extensive hydrogen bonding and hydrophobic interactions within and between the &beta;-sheets render the fibrils <strong>extremely insoluble in physiological fluids</strong>. This leads to their progressive accumulation in tissues.</li><li><strong>Congo Red Staining &amp; Birefringence:</strong> The specific spatial arrangement of the &beta;-pleated sheets allows the Congo red dye to intercalate, resulting in the pathognomonic <strong>apple-green birefringence</strong> under polarized light. This is a diagnostic hallmark.</li></ul><p><strong>Pathophysiology of Disease:</strong></p><ul><li>The <strong>insolubility</strong> and <strong>protease resistance</strong> of the amyloid fibrils are directly responsible for the disease pathology.</li><li>As these inert, physically rigid deposits accumulate in organs like the kidney, heart, liver, and nerves, they disrupt tissue architecture and function, leading to organ failure (e.g., renal failure, cardiomyopathy, neuropathy).</li><li>The <strong>macroglossia</strong> is a direct result of amyloid infiltration in the tongue.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>High solubility and rapid clearance </strong><strong>(Option A):</strong> This is the opposite of what occurs. The &beta;-pleated sheet structure confers <strong>insolubility</strong> and <strong>poor clearance</strong>, leading to accumulation.</p><p><strong>Increased antigenicity and immune activation </strong><strong>(Option C):</strong> While inflammation can be associated, the primary damage is not due to an immune response against the fibrils. The fibrils themselves are relatively inert but cause physical disruption.</p><p><strong>Enhanced enzymatic activity </strong><strong>(Option D):</strong> The proteins that form amyloid (e.g., immunoglobulin light chains, serum amyloid A) lose their normal biological function when they misfold into the amyloid conformation. They do not gain new enzymatic activity.</p><p><strong>Key Takeaways:</strong></p><p>Amyloid deposits are composed of two main components:</p><ol><li><strong>Fibril Protein:</strong> The major component (95%), which varies depending on the type of amyloidosis (e.g., AL - Light chains; AA - Serum Amyloid A; A&beta; - in Alzheimer's disease).</li><li><strong>P Component (AP):</strong> A glycoprotein that makes up about 5% of the deposit and stabilizes the fibrils.</li></ol>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetyl-CoA</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">NAD+</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactate</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">NADH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man with a history of chronic alcohol use is brought to the emergency department with hypoglycemia. The hypoglycemia in this scenario can be attributed to the inhibition of a critical metabolic pathway in the liver. Which of the following substrates, when present in high concentration due to alcohol metabolism, directly inhibits a key enzyme of gluconeogenesis, thereby contributing to hypoglycemia?</span></p>",
      "unique_key": "Q319498",
      "question_audio": null,
      "question_video": null,
      "map_id": 319498,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The scenario describes alcohol-induced hypoglycemia, a classic example of disrupted gluconeogenesis.</p><p><strong>Metabolic Consequences of Alcohol Metabolism:</strong></p><ul><li>Alcohol is metabolized in the liver primarily by two enzymes: <strong>Alcohol Dehydrogenase (ADH)</strong> and <strong>Aldehyde Dehydrogenase (ALDH)</strong>.</li><li>Both of these reactions <strong>generate NADH from NAD+</strong>.</li><li><strong>ADH:</strong> Ethanol + NAD+ &rarr; Acetaldehyde + NADH + H+</li><li><strong>ALDH:</strong> Acetaldehyde + NAD+ + H2O &rarr; Acetate + NADH + H+</li><li>This leads to a significantly <strong>high NADH/NAD+ ratio</strong> in the hepatic cytoplasm.</li></ul><p><strong>Inhibition of Gluconeogenesis by High NADH:</strong></p><ul><li>Gluconeogenesis requires a balanced ratio of NAD+/NADH for its reversible reactions to proceed in the direction of glucose synthesis.</li><li>A high NADH/NAD+ ratio specifically inhibits the conversion of <strong>lactate to pyruvate</strong> and <strong>glycerol-3-phosphate to glycerol</strong>.</li><li><strong>Lactate Pathway:</strong><ul><li>Lactate is a crucial gluconeogenic precursor.</li><li>The enzyme <strong>Lactate Dehydrogenase (LDH)</strong> normally converts lactate to pyruvate using NAD+.</li><li>A high NADH level shifts the LDH equilibrium backwards, favoring the formation of lactate from pyruvate.</li><li>This <strong>traps lactate</strong> and prevents its conversion to pyruvate, a key starting point for gluconeogenesis.</li></ul></li><li><strong>Glycerol Pathway:</strong><ul><li>Glycerol enters gluconeogenesis via conversion to glycerol-3-phosphate (by glycerol kinase) and then to dihydroxyacetone phosphate (DHAP) by <strong>Glycerol-3-Phosphate Dehydrogenase</strong>, which requires NAD+ as a cofactor.</li><li>A high NADH level inhibits this enzyme, blocking glycerol's entry into gluconeogenesis.</li></ul></li></ul><p><strong>Overall Effect:</strong></p><ul><li>By shutting down these two major pathways for gluconeogenic precursors (lactate and glycerol), the high NADH level induced by alcohol metabolism severely impairs the liver's ability to produce new glucose during fasting, leading to <strong>hypoglycemia</strong>.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Acetyl-CoA </strong><strong>(Option A):</strong> Acetyl-CoA is actually an <strong>activator</strong> of pyruvate carboxylase, the first enzyme of gluconeogenesis that converts pyruvate to oxaloacetate. It does not inhibit gluconeogenesis.</p><p><strong>NAD+ </strong><strong>(Option B):</strong> This is the oxidized form. Its concentration decreases during alcohol metabolism. It is a necessary cofactor for reactions in gluconeogenesis (e.g., for LDH to convert lactate to pyruvate), not an inhibitor.</p><p><strong>Lactate </strong><strong>(Option C):</strong> Lactate is a <strong>substrate</strong> for gluconeogenesis (via the Cori cycle). It is not an inhibitor; rather, its utilization is prevented by the high NADH levels.</p><p><strong>Key Takeaways:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/11E.png\"><p>Gluconeogenesis bypasses the three irreversible steps of glycolysis with four specific enzymes:</p><ul><li><strong>Pyruvate carboxylase</strong> and <strong>Phosphoenolpyruvate carboxykinase (PEPCK)</strong> bypass Pyruvate kinase.</li><li><strong>Fructose-1,6-bisphosphatase</strong> bypasses Phosphofructokinase-1 (PFK-1).</li><li><strong>Glucose-6-phosphatase</strong> bypasses Glucokinase/Hexokinase.</li></ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver phosphorylase kinase deficiency</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver glycogen phosphorylase deficiency</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose-6-phosphatase deficiency</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Debranching enzyme deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">5-year-old boy presents with hepatomegaly and growth retardation. Laboratory studies reveal mild hypoglycemia and hyperlipidemia. On administration of glucagon, there is no rise in blood glucose concentration. Liver biopsy shows accumulation of glycogen with normal structure. Which of the following enzyme deficiencies is most likely responsible?</span></p>",
      "unique_key": "Q319499",
      "question_audio": null,
      "question_video": null,
      "map_id": 319499,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation</strong></p><ul><li>Hers disease (GSD type VI) is caused by deficiency of <strong>liver glycogen phosphorylase</strong>, the key enzyme in glycogenolysis.</li><li>Without this enzyme, hepatocytes cannot degrade glycogen to glucose-1-phosphate, so glycogen accumulates in the liver.</li><li><strong>Diagnostic clue:</strong> administration of glucagon does not increase blood glucose, because the pathway is blocked at the final step of glycogen breakdown.</li><li>Clinical features: hepatomegaly, growth retardation, mild fasting hypoglycemia, ketosis, and hyperlipidemia. The condition is generally milder than Von Gierke's disease.</li></ul><p><strong>Hepatic Glycogen Storage Diseases</strong></p><ul><li><strong>Type I (Von Gierke's, glucose-6-phosphatase deficiency):</strong> severe fasting hypoglycemia, lactic acidosis, hyperuricemia, hepatomegaly, \"doll-like facies.\"</li><li><strong>Type III (Cori's, debranching enzyme deficiency):</strong> hepatomegaly, fasting hypoglycemia, abnormal glycogen with short outer chains.</li><li><strong>Type VI (Hers disease, liver phosphorylase deficiency):</strong> mild hypoglycemia, hepatomegaly, normal glycogen structure, no glycemic rise with glucagon.</li><li><strong>Type IX (phosphorylase kinase deficiency):</strong> similar to type VI, often X-linked, variable severity.</li></ul><p><strong>Explanation of Other Options</strong></p><ul><li><strong>Liver phosphorylase kinase deficiency (Option A):</strong> This causes <strong>GSD IX</strong>, not GSD VI. Patients may have similar findings, but inheritance is often X-linked, and glucagon response may be variably impaired.</li><li><strong>Glucose-6-phosphatase deficiency (Option C):</strong> This is <strong>GSD I (Von Gierke's)</strong>, with much more severe fasting hypoglycemia, lactic acidosis, and characteristic facies.</li><li><strong>Debranching enzyme deficiency (Option D):</strong> This is <strong>GSD III (Cori's disease)</strong>, where glycogen has short outer chains, and hypoglycemia is more pronounced.</li></ul>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Complex I (NADH Dehydrogenase)</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Complex II (Succinate Dehydrogenase)</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Complex III (Cytochrome bc1 Complex)</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Complex IV (Cytochrome c Oxidase)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man is brought to the emergency department after being found unconscious in a closed garage with the car engine running. His arterial blood is noted to be cherry-red in color. The toxic compound involved in this poisoning exerts its lethal effect by primarily inhibiting which of the following components of the mitochondrial electron transport chain?</span></p>",
      "unique_key": "Q319500",
      "question_audio": null,
      "question_video": null,
      "map_id": 319500,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The scenario describes a classic case of <strong>Carbon Monoxide (CO) Poisoning</strong>.</p><p><strong>Mechanism of Toxicity:</strong></p><ul><li>Carbon monoxide has a <strong>very high affinity (about 250 times greater than oxygen) for the heme iron</strong> in hemoglobin and cytochromes.</li><li>In the Electron Transport Chain (ETC), <strong>Complex IV (Cytochrome c Oxidase)</strong> contains two heme centers (heme a and heme a3) and a copper center, which are critical for the final transfer of electrons to molecular oxygen.</li><li>CO binds irreversibly to the <strong>heme a3</strong> component of Complex IV, blocking the reduction of oxygen to water.</li></ul><p><strong>Consequences of Inhibition:</strong></p><ul><li><strong>Halting of Electron Flow:</strong> Inhibition of Complex IV causes a complete backup of electrons throughout the entire chain.</li><li><strong>Cessation of Oxidative Phosphorylation:</strong> Without the flow of electrons to oxygen, the proton gradient across the inner mitochondrial membrane cannot be maintained, and ATP synthesis stops.</li><li><strong>Cellular Hypoxia and Death:</strong> Tissues with high oxygen demand, like the brain and heart, are affected first, leading to loss of consciousness and organ failure.</li></ul><p><strong>Correlation with Clinical Feature:</strong></p><ul><li><strong>Cherry-Red Color of Blood:</strong> CO binding to hemoglobin forms <strong>carboxyhemoglobin (COHb)</strong>, which has a characteristic bright red color, explaining the cherry-red appearance of the skin and blood.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/13E.png\"><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Complex I (NADH Dehydrogenase) </strong><strong>(Option A):</strong> Inhibited by <strong>Rotenone</strong> (insecticide) and <strong>Amobarbital</strong>. Causes backup from NADH-linked substrates but electrons from FADH2 (via Complex II) can still flow.</p><p><strong>Complex II (Succinate Dehydrogenase) </strong><strong>(Option B):</strong> Inhibited by <strong>Malonate</strong> (competitive inhibitor of succinate). Affects only the FADH2 pathway from succinate.</p><p><strong>Complex III (Cytochrome bc1 Complex) </strong><strong>(Option C):</strong> Inhibited by <strong>Antimycin A</strong>. Blocks electron transfer from cytochrome b to c1, causing reduction of all components before it and oxidation of components after it.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/13E1.png\">",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Fructose</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactose</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old child presents with failure to thrive, hepatosplenomegaly, and vomiting. Laboratory investigations reveal hypoglycemia and a positive reducing sugar test in the urine. However, the glucose oxidase test (dipstick for glucose) on the same urine sample is negative. The sugar most likely excreted in the urine in this case is:</span></p>",
      "unique_key": "Q319501",
      "question_audio": null,
      "question_video": null,
      "map_id": 319501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical and laboratory findings are classic for <strong>Classic Galactosemia</strong>, caused by a deficiency of the enzyme <strong>Galactose-1-Phosphate Uridyltransferase (GALT)</strong>.</p><p><strong>Analysis of Urine Test Results:</strong></p><ul><li><strong>Positive Reducing Sugar Test:</strong> This test (e.g., Benedict's test) is positive for any sugar with a free aldehyde or ketone group, including <strong>glucose, galactose, fructose, and lactose</strong>.</li><li><strong>Negative Glucose Oxidase Test:</strong> This test is highly specific for <strong>glucose</strong>.</li><li>The discrepancy (Reducing substances present but glucose absent) indicates the presence of a <strong>non-glucose reducing sugar</strong> in the urine.</li></ul><p><strong>Identifying the Sugar - Galactosemia:</strong></p><ul><li>In Galactosemia, the metabolic block prevents the conversion of galactose to glucose.</li><li>This leads to the accumulation of galactose and its metabolites (galactitol, galactonate) in the blood.</li><li>The high blood levels exceed the renal threshold, leading to <strong>galactosuria</strong> (galactose in urine).</li><li>Galactose is a reducing sugar but is not detected by the glucose-specific dipstick, perfectly explaining the test results.</li></ul><p><strong>Correlation with Clinical Features:</strong></p><ul><li><strong>Failure to thrive, vomiting, hepatosplenomegaly:</strong> Caused by the toxic accumulation of <strong>galactose-1-phosphate</strong> in cells, leading to liver damage, renal tubular dysfunction, and general metabolic disruption.</li><li><strong>Hypoglycemia:</strong> Occurs because the conversion of galactose into glucose is blocked, and the toxicity can impair hepatic glucose output.</li><li>If untreated, the condition can progress to cataracts (due to galactitol accumulation in the lens) and intellectual disability.</li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Glucose (Option A):</strong> This would cause both tests to be positive (e.g., in untreated diabetes mellitus or renal glycosuria).</p><p><strong>Fructose (Option B):</strong> Fructosuria is seen in <strong>Essential Fructosuria</strong> (a benign condition due to fructokinase deficiency) or <strong>Hereditary Fructose Intolerance</strong> (Aldolase B deficiency). However, symptoms are typically triggered only by fructose/sucrose ingestion, and hypoglycemia is not a primary feature.</p><p><strong>Lactose (Option C):</strong> Lactosuria is rare and is typically seen in late pregnancy or during lactation. It is not associated with the acute infantile presentation of failure to thrive and hepatosplenomegaly described.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/14E.png\">",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Malonate</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoroacetate</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Arsenite</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Oligomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man presents with severe metabolic acidosis. Laboratory analysis reveals a high anion gap acidosis with elevated levels of lactate and citrate in the blood. The elevated citrate level is a key diagnostic clue. This presentation is most consistent with poisoning by which of the following compounds that inhibits a critical step in the TCA cycle?</span></p>",
      "unique_key": "Q319502",
      "question_audio": null,
      "question_video": null,
      "map_id": 319502,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The scenario describes poisoning with <strong>Fluoroacetate</strong> (found in some rodenticides), which is metabolized to <strong>Fluorocitrate</strong>, a potent inhibitor of the TCA cycle.</p><p><strong>Mechanism of Toxicity:</strong></p><ul><li>Fluoroacetate is converted to <strong>fluoroacetyl-CoA</strong> in the body.</li><li>Fluoroacetyl-CoA enters the TCA cycle and condenses with oxaloacetate, via the enzyme <strong>citrate synthase</strong>, to form <strong>fluorocitrate</strong>.</li><li>Fluorocitrate is a <strong>suicide inhibitor</strong> of the enzyme <strong>aconitase</strong>, which catalyzes the conversion of citrate to isocitrate.</li></ul><p><strong>Consequences of Aconitase Inhibition:</strong></p><ul><li><strong>Accumulation of Citrate:</strong> The blockade at the aconitase step leads to a massive accumulation of citrate upstream of the metabolic block.</li><li><strong>Inhibition of TCA Cycle:</strong> The entire TCA cycle halts because the flow of metabolites is blocked.</li><li><strong>Impaired ATP Production:</strong> Cessation of the TCA cycle leads to a failure of aerobic ATP production.</li><li><strong>Metabolic Acidosis:</strong> The cell shifts to anaerobic glycolysis for energy, leading to <strong>lactic acid accumulation</strong> (lactic acidosis). The combination of lactate and citrate accumulation contributes to the <strong>high anion gap metabolic acidosis</strong>.</li></ul><p><strong>Correlation with Clinical Features:</strong></p><ul><li>The specific finding of <strong>elevated blood citrate</strong> is a hallmark of fluoroacetate poisoning and directly points to the inhibition of aconitase<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/15E.png\"></li></ul><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Malonate (Option A):</strong> Malonate is a <strong>competitive inhibitor of succinate dehydrogenase (Complex II of ETC and TCA cycle)</strong>. It would cause accumulation of succinate, not citrate. It also causes lactic acidosis but does not characteristically increase citrate levels.</p><p><strong>Arsenite (Option C):</strong> Arsenite inhibits enzyme complexes with lipoic acid as a cofactor, primarily <strong>pyruvate dehydrogenase (PDH)</strong> and <strong>&alpha;-ketoglutarate dehydrogenase</strong>. This would lead to accumulation of pyruvate and lactate (acidosis), but not citrate.</p><p><strong>Oligomycin (Option D):</strong> Oligomycin inhibits <strong>ATP synthase (Complex V)</strong> of oxidative phosphorylation. It does not directly inhibit any TCA cycle enzyme and would not cause a specific accumulation of citrate.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/15E1.png\">",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Tryptophan</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Methionine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-month-old infant presents with recurrent episodes of cerebellar ataxia, nystagmus, and photosensitive skin rash. The symptoms are intermittent and improve with niacin supplementation. Urinalysis reveals increased indoles, indican, and indoleacetic acid. This condition is most likely due to a defect in the transport of which of the following amino acids?</span></p>",
      "unique_key": "Q319503",
      "question_audio": null,
      "question_video": null,
      "map_id": 319503,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical presentation is classic for <strong>Hartnup Disease</strong>, a disorder of neutral amino acid transport.</p><p><strong>Defective Transporter &amp; Pathophysiology:</strong></p><ul><li>Hartnup disease is caused by an autosomal recessive mutation in the <strong>SLC6A19</strong></li><li>This gene codes for a sodium-dependent and chloride-independent <strong>neutral amino acid transporter</strong> in the renal tubules and intestinal mucosa.</li><li>The defective transporter impairs the absorption of neutral amino acids, including <strong>tryptophan</strong>, from the gut and their reabsorption in the kidneys.</li></ul><p><strong>Consequences of Tryptophan Malabsorption:</strong></p><ul><li>Tryptophan is a precursor for the synthesis of <strong>Niacin (Vitamin B3)</strong>.</li><li>Malabsorption leads to <strong>Niacin deficiency</strong>, which causes the pellagra-like symptoms:<ul><li><strong>Photosensitive skin rash</strong></li><li><strong>Cerebellar ataxia</strong> (due to impaired neurotransmitter synthesis and/or niacin deficiency affecting the nervous system)</li><li>Other neurological symptoms like nystagmus and psychiatric disturbances.</li></ul></li><li>The unabsorbed tryptophan in the gut is metabolized by colonic bacteria into <strong>indoles</strong> (e.g., indican, indoleacetic acid), which are absorbed and excreted in large amounts in the urine.</li></ul><p><strong>Correlation of Clinical Features:</strong></p><ul><li><strong>Intermittent Symptoms:</strong> Symptoms flare up during periods of increased metabolic demand, poor nutrition, or infection.</li><li><strong>Response to Niacin:</strong> Supplementation bypasses the block in the tryptophan-to-niacin pathway and effectively treats the symptoms.</li><li><strong>Urinary Findings:</strong> The presence of high levels of indole derivatives is a diagnostic hallmark of the disease.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Phenylalanine (Option A):</strong> A transport defect for phenylalanine is not a recognized clinical entity. Phenylketonuria (PKU) is due to a defect in its metabolism (phenylalanine hydroxylase), not transport.</p><p><strong>Tyrosine (Option C):</strong> Defects in tyrosine metabolism cause conditions like Tyrosinemia, which presents with liver failure, renal tubular dysfunction, and a \"cabbage-like\" odor, not the pellagra-like symptoms seen here.</p><p><strong>Methionine (Option D):</strong> A defect in methionine metabolism is seen in Homocystinuria, which presents with marfanoid habitus, ectopia lentis, and thromboembolism.</p><p><strong>Key Takeaways:</strong></p><p>Tryptophan is a precursor for several crucial molecules:</p><ol><li><strong>Serotonin (5-HT):</strong> A neurotransmitter.</li><li><strong>Melatonin:</strong> A hormone regulating sleep-wake cycles.</li><li><strong>Niacin (Vitamin B3):</strong> A vitamin and component of the coenzymes NAD+ and NADP+.</li></ol>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">It is an X-linked dominant disorder resulting in a non-functional phenylalanine hydroxylase enzyme monomer.</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">It is an autosomal recessive disorder where the mutant enzyme subunit disrupts the function of the tetrameric protein.</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">It is an autosomal dominant disorder with a single mutant allele causing haploinsufficiency.</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a mitochondrial disorder affecting the hepatic urea cycle enzyme phenylalanine transaminase.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A couple with no family history of metabolic disorders gives birth to a child who is diagnosed with classic phenylketonuria (PKU) via newborn screening. Genetic analysis reveals a missense mutation in the PAH gene. The parents are both confirmed to be heterozygous carriers for this mutation. Which of the following statements accurately describes the most likely molecular consequence and inheritance pattern in this case?</span></p>",
      "unique_key": "Q319504",
      "question_audio": null,
      "question_video": null,
      "map_id": 319504,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li>Classic PKU follows an <strong>autosomal recessive</strong> inheritance pattern.<ul><li>Both parents of an affected child are typically <strong>asymptomatic heterozygous carriers</strong>.</li><li>The child must inherit two mutant alleles (one from each parent) to manifest the disease.</li><li>The scenario described, with unaffected carrier parents and an affected child, is classic for autosomal recessive inheritance.<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/17E.png\"></li></ul></li><li>The enzyme deficient in PKU is <strong>Phenylalanine Hydroxylase (PAH)</strong>.</li><li>PAH functions as a <strong>homotetramer</strong> - meaning it is composed of four identical polypeptide subunits.</li><li>A missense mutation in the PAH gene leads to the production of an abnormal (mutant) subunit.</li><li>In a heterozygous carrier, the presence of some normal subunits can form functional or partially functional tetramers, which is why carriers are asymptomatic.</li><li>In a homozygous affected individual, only mutant subunits are produced.</li><li>These mutant subunits can assemble into the tetrameric structure, but the presence of even one abnormal subunit can often <strong>disrupt the proper folding, stability, or catalytic activity of the entire enzyme complex</strong>.</li><li>This is a dominant-negative effect at the protein level, even though the inheritance is recessive at the genetic level.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>X-linked dominant (Option A):</strong> PKU is not X-linked; the PAH gene is located on <strong>chromosome 12</strong>, an autosome. It is recessive, not dominant.</p><p><strong>Autosomal dominant with haploinsufficiency (Option C):</strong> In haploinsufficiency, one functional copy of the gene is not enough to produce a normal phenotype. PKU is not dominant; heterozygotes (with one functional copy) are phenotypically normal. The disease requires two mutant alleles.</p><p><strong>Mitochondrial disorder affecting phenylalanine transaminase (Option D):</strong> PKU is a nuclear genetic disorder, not mitochondrial. The deficient enzyme is <strong>phenylalanine hydroxylase</strong>, not transaminase. It primarily affects the liver's ability to process phenylalanine, not the urea cycle.</p><p><strong>Key Takeaways:</strong></p><p>There are over <strong>500 different mutations</strong> identified in the PAH gene, which explains the wide spectrum of clinical severity in PKU:</p><ul><li><strong>Classic PKU:</strong> Most severe, with virtually no enzyme activity (&lt;1%).</li><li><strong>Variant PKU:</strong> Moderate enzyme activity (1-5%).</li><li><strong>Non-PKU Hyperphenylalaninemia (Mild HPA):</strong> Higher enzyme activity (&gt;5%), often requiring less strict dietary management.</li></ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Tryptophan</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Histidine</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient presents with episodic headaches, palpitations, and profuse sweating. Diagnostic workup confirms a pheochromocytoma. The catecholamines hypersecreted by this tumor-epinephrine, norepinephrine, and dopamine-are all derived from a single amino acid precursor. This precursor is also the starting point for the synthesis of melanin and thyroid hormones. Which of the following amino acids serves this crucial biosynthetic role?</span></p>",
      "unique_key": "Q319505",
      "question_audio": null,
      "question_video": null,
      "map_id": 319505,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li><strong>Tyrosine</strong> is the direct precursor amino acid for the synthesis of all catecholamines.</li><li>The biosynthetic pathway is:<ul><li><strong>Phenylalanine &#8594; Tyrosine</strong> (via Phenylalanine Hydroxylase)</li><li><strong>Tyrosine &#8594; DOPA</strong> (via Tyrosine Hydroxylase - Rate-Limiting Step)</li><li><strong>DOPA &#8594; Dopamine</strong> (via DOPA Decarboxylase)</li><li><strong>Dopamine &#8594; Norepinephrine</strong> (via Dopamine &beta;-Hydroxylase)</li><li><strong>Norepinephrine &#8594; Epinephrine</strong> (via Phenylethanolamine N-methyltransferase, PNMT)</li></ul></li></ul><p><strong>Role in Pheochromocytoma:</strong></p><ul><li>A pheochromocytoma is a tumor of the chromaffin cells of the adrenal medulla.</li><li>These cells possess the entire enzymatic machinery to convert tyrosine into catecholamines.</li><li>The tumor causes <strong>uncontrolled, excessive production and secretion</strong> of these hormones, leading to the classic triad of episodic headaches, sweating, and tachycardia.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Tryptophan </strong><strong>(Option A):</strong> This is the precursor for serotonin (5-hydroxytryptamine) and melatonin, not for catecholamines.</p><p><strong>Histidine </strong><strong>(Option B):</strong> This is the precursor for histamine, not catecholamines.</p><p><strong>Phenylalanine </strong><strong>(Option D):</strong> While phenylalanine is indirectly involved as it is converted to tyrosine, it is <strong>tyrosine</strong> that is the direct and immediate precursor for catecholamine synthesis. In a biochemical context focused on the final biosynthetic pathway, tyrosine is the correct answer.</p><p><strong>Key Takeaways:</strong></p><p><strong>Phenylalanine &#8594; Tyrosine &#8594; DOPA &#8594; Dopamine &#8594; Norepinephrine &#8594; Epinephrine</strong></p><ul><li><strong>Key Enzymes:</strong><ul><li><strong>Tyrosine Hydroxylase:</strong> Rate-limiting step (inhibited by end-product catecholamines).</li><li><strong>DOPA Decarboxylase:</strong> Requires Pyridoxal Phosphate (Vitamin B6).</li><li><strong>Dopamine &beta;-Hydroxylase:</strong> Contains Ascorbic Acid (Vitamin C).</li><li><strong>PNMT:</strong> Highly expressed in the adrenal medulla; its synthesis is induced by cortisol.</li></ul></li></ul>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine, Tyrosine, Tryptophan</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Leucine, Isoleucine, Valine</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Methionine, Homocysteine, Cysteine</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycine, Serine, Alanine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A newborn, born of a consanguineous marriage, presents with poor feeding, vomiting, and alternating periods of hypertonia and hypotonia. On examination, the physician notes a characteristic sweet, maple syrup-like odor to the urine and cerumen. This presentation is pathognomonic for a defect in the oxidative decarboxylation of branched-chain amino acids. Which of the following combinations of amino acids accumulates in this disorder?</span></p>",
      "unique_key": "Q319506",
      "question_audio": null,
      "question_video": null,
      "map_id": 319506,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical description is classic for <strong>Maple Syrup Urine Disease (MSUD)</strong>, also known as Branched-Chain Ketoaciduria.</p><p><strong>Defective Enzyme Complex:</strong></p><ul><li>MSUD is caused by a deficiency in the <strong>Branched-Chain &alpha;-Ketoacid Dehydrogenase (BCKDH) Complex</strong>.</li><li>This mitochondrial enzyme complex is responsible for the <strong>oxidative decarboxylation</strong> of the &alpha;-keto acids derived from the branched-chain amino acids (BCAAs). It is analogous to the pyruvate dehydrogenase complex.</li></ul><p><strong>Metabolic Block and Accumulation:</strong></p><ul><li>The BCKDH complex catalyzes the second step in the catabolism of BCAAs, which is irreversible and rate-limiting.</li><li>Due to the enzyme deficiency, the following accumulate in the blood and tissues:<ul><li>The three <strong>Branched-Chain Amino Acids</strong>: <strong>Leucine, Isoleucine, and Valine</strong>.</li><li>Their corresponding <strong>&alpha;-Ketoacids</strong>: &alpha;-Ketoisocaproic acid (from leucine), &alpha;-Keto-&beta;-methylvaleric acid (from isoleucine), and &alpha;-Ketoisovaleric acid (from valine).</li></ul></li></ul><p><strong>Pathogenesis of Clinical Features:</strong></p><ul><li><strong>Characteristic Odor:</strong> The accumulated &alpha;-ketoacid from isoleucine, &alpha;-Keto-&beta;-methyl-valeric acid, is responsible for the <strong>sweet, maple syrup-like odor</strong> in the urine, sweat, and cerumen.</li><li><strong>Neurological Symptoms (Poor feeding, vomiting, alternating tone):</strong><ul><li>This is primarily due to the <strong>neurotoxicity of elevated leucine</strong> and its ketoacid.</li><li>Leucine competes with other large neutral amino acids for transport across the blood-brain barrier, leading to cerebral deficiency of neurotransmitters and energy crisis.</li><li>The ketoacids also contribute to severe metabolic acidosis.</li></ul></li><li><strong>Consanguinity:</strong> Points towards an autosomal recessive inheritance pattern, which is the case for MSUD.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Phenylalanine, Tyrosine, Tryptophan </strong><strong>(Option A):</strong> These are aromatic amino acids. Phenylalanine and tyrosine accumulation is seen in PKU and tyrosinemia, respectively. Tryptophan is not typically associated with a major accumulation disorder presenting in this manner.</p><p><strong>Methionine, Homocysteine, Cysteine </strong><strong>(Option C):</strong> These are sulfur-containing amino acids. Their accumulation is characteristic of <strong>Homocystinuria</strong> (cystathionine &beta;-synthase deficiency) or <strong>Methylmalonic Acidemia</strong>.</p><p><strong>Glycine, Serine, Alanine </strong><strong>(Option D):</strong> These are non-branched, small amino acids. Glycine accumulation is seen in <strong>Non-ketotic Hyperglycinemia</strong>, which presents with severe neonatal seizures and hiccups, not a maple syrup odor.</p><p><strong>Key Takeaways:</strong></p><p>The catabolic pathway for BCAAs involves two key steps:</p><ol><li><strong>Transamination:</strong> BCAA &#8594; Branched-Chain &alpha;-Ketoacid (BCKA) (Reversible)</li><li><strong>Oxidative Decarboxylation:</strong> BCKA &#8594; Acyl-CoA derivative (Irreversible)<br> Enzyme: <strong>Branched-Chain &alpha;-Ketoacid Dehydrogenase Complex</strong><br> This is the step blocked in MSUD.</li></ol>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxidative deamination for ammonia production</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Transfer of amino groups for nitrogen disposal</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaplerotic replenishment of TCA cycle intermediates</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Irreversible commitment of amino acids to degradation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The enzymes ALT and AST are serum markers for liver damage. They catalyze a reaction that involves the reversible transfer of an amino group from an amino acid to an &alpha;-keto acid. What is the primary physiological purpose of this transamination reaction?</span></p>",
      "unique_key": "Q319507",
      "question_audio": null,
      "question_video": null,
      "map_id": 319507,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The question describes the function of <strong>transaminases</strong> (Aminotransferases), specifically Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST), which are classic markers of liver cell injury.</p><p><strong>Definition and Mechanism of Transamination:</strong></p><ul><li>Transamination is the <strong>reversible transfer of an &alpha;-amino group</strong> from an amino acid to an &alpha;-keto acid.</li><li>This reaction results in the formation of a new amino acid and a new &alpha;-keto acid.</li><li>The reaction is freely reversible and does not result in a net gain or loss of amino groups.</li></ul><p><strong>Role of the Coenzyme:</strong></p><ul><li>All transaminases require <strong>Pyridoxal Phosphate (PLP)</strong>, the active form of Vitamin B6, as an essential cofactor.</li><li>PLP acts as an intermediate carrier of the amino group. It accepts the amino group from the donor amino acid to form Pyridoxamine Phosphate (PMP) and then donates it to the acceptor &alpha;-keto acid.</li></ul><p><strong>Primary Biochemical Function:</strong></p><ul><li>The primary function of transamination is the <strong>redistribution and \"funneling\" of amino groups</strong>.</li><li>Most amino acids transfer their amino groups to a small number of key &alpha;-keto acids, primarily <strong>&alpha;-ketoglutarate</strong>, to form <strong>glutamate</strong>.</li><li>This process serves as the first step in amino acid catabolism, collecting nitrogen from various sources into glutamate. The nitrogen from glutamate can then be used for biosynthesis or be channeled into the urea cycle for <strong>final disposal</strong> via oxidative deamination.</li></ul><p><strong>Clinical Correlation:</strong></p><ul><li>In liver disease, hepatocyte necrosis leads to the release of intracellular enzymes like ALT and AST into the bloodstream, causing elevated serum levels.</li><li>The transamination reaction itself does not produce ammonia; it only transfers the amino group. The ammonia for the urea cycle is primarily generated later by the oxidative deamination of glutamate by <strong>GlutamateDehydrogenase (GDH)</strong>.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Oxidative deamination for ammonia production </strong><strong>(Option A):</strong> This is the function of enzymes like <strong>Glutamate Dehydrogenase</strong>, which liberates free ammonia (NH&#8323;) from glutamate. Transamination does not release ammonia.</p><p><strong>Anaplerotic replenishment of TCA cycle intermediates </strong><strong>(Option C):</strong> While transamination can produce TCA cycle intermediates (e.g., alanine &#8594; pyruvate; aspartate &#8594; oxaloacetate), this is a secondary function. The primary function is nitrogen transfer, not anaplerosis.</p><p><strong>Irreversible commitment of amino acids to degradation </strong><strong>(Option D):</strong> Transamination is a <strong>reversible</strong> reaction. It does not irreversibly commit an amino acid to degradation. The irreversible step is typically the subsequentoxidative deamination or other specific reactions.</p><p><strong>Key Takeaways:</strong></p><ol><li><strong>Alanine + &alpha;-Ketoglutarate &#8652; Pyruvate + Glutamate</strong><br> (Catalyzed by Alanine Aminotransferase, ALT)</li><li><strong>Aspartate + &alpha;-Ketoglutarate &#8652; Oxaloacetate + Glutamate</strong><br> (Catalyzed by Aspartate Aminotransferase, AST)</li></ol><p><strong>Significance:</strong> These reactions link amino acid metabolism with carbohydrate metabolism (via pyruvate and oxaloacetate) and centralize nitrogen in glutamate.</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">&alpha;-Helix</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">&beta;-Pleated Sheet</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Triple Helix</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Random Coil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with systemic amyloidosis has tissue deposits of insoluble protein fibrils that show apple-green birefringence with Congo red stain. The stability, insolubility, and diagnostic staining of these fibrils are due to their characteristic quaternary structure, which is:</span></p>",
      "unique_key": "Q319508",
      "question_audio": null,
      "question_video": null,
      "map_id": 319508,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical scenario describes <strong>Systemic Amyloidosis</strong>, where misfolded proteins form insoluble amyloid fibrils that deposit in tissues.</p><p><strong>Pathological Protein Structure in Amyloidosis:</strong></p><ul><li>The defining structural feature of all amyloid fibrils is the <strong>cross &beta;-pleated sheet conformation</strong>.</li><li>In this configuration, &beta;-strands run perpendicular to the long axis of the fibril, and multiple &beta;-sheets are stacked on top of each other.</li></ul><p><strong>Cross &beta;-pleated sheet conformation:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/21E.png\"><p><strong>Consequences of the &beta;-Sheet Structure:</strong></p><ul><li><strong>Protease Resistance:</strong> The extensive hydrogen bonding within and between the &beta;-sheets creates a highly stable, tightly packed structure that is resistant to proteolytic degradation. This leads to the accumulation of the fibrils.</li><li><strong>Insolubility:</strong> The hydrogen bonding and hydrophobic interactions make the fibrils extremely insoluble in physiological fluids.</li><li><strong>Congo Red Staining &amp; Birefringence:</strong> The specific spatial arrangement of the &beta;-pleated sheets allows the Congo red dye to intercalate, resulting in the pathognomonic <strong>apple-green birefringence</strong> under polarized light. This is a direct result of the quaternary &beta;-sheet structure.</li></ul><p><strong>Pathophysiology:</strong></p><ul><li>The deposition of these rigid, insoluble &beta;-sheet fibrils in organs (like kidneys, nerves, and heart) disrupts tissue architecture and function, leading to the clinical manifestations of organ failure (proteinuria, neuropathy, etc.).</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>&alpha;-Helix </strong><strong>(Option A):</strong> This is a common secondary structure in many functional, globular proteins (e.g., myoglobin, hemoglobin). It is stabilized by hydrogen bonds parallel to the helix axis. Amyloid fibrils are not primarily composed of &alpha;-helices.</p><p><strong>Triple Helix </strong><strong>(Option C):</strong> This is a unique structure found in <strong>collagen</strong>, where three polypeptide chains are wound around each other. It is not the structure of amyloid fibrils.</p><p><strong>Random Coil </strong><strong>(Option D):</strong> This refers to an unstructured, flexible polypeptide segment. While proteins may be unstructured before folding, the final, pathological amyloid aggregate is a highly ordered, structured &beta;-sheet assembly, not a random coil.</p><p><strong>Key Takeaways:</strong></p><ul><li><strong>Primary Structure:</strong> The linear sequence of amino acids.</li><li><strong>Secondary Structure:</strong> Local folded structures (&alpha;-helix, &beta;-sheet) stabilized by hydrogen bonds.</li><li><strong>Tertiary Structure:</strong> The overall 3D shape of a single polypeptide chain.</li><li><strong>Quaternary Structure:</strong> The assembly of multiple polypeptide chains (subunits). The cross-&beta; spine of an amyloid fibril is a form of quaternary structure.</li></ul>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">To maintain the pH of urine</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">To facilitate enzymatic catalysis in the stomach</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">To buffer lactic acid produced in skeletal muscle</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">To transport carbon dioxide as carbamate in the blood</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The unique buffering capacity of amino acids in a solution is primarily attributed to their ability to act as zwitterions. What is the primary physiological role of the buffering action provided by the amino acid histidine, specifically in a protein-like hemoglobin?</span></p>",
      "unique_key": "Q319509",
      "question_audio": null,
      "question_video": null,
      "map_id": 319509,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li>Among the 20 standard amino acids, <strong>Histidine</strong> has a side chain (imidazole ring) with a pKa of approximately <strong>0</strong>.</li><li>This pKa value is very close to the physiological pH of 7.4, making it an <strong>excellent physiological buffer</strong>.</li><li>At pH 7.4, the imidazole group can readily accept or donate a proton.</li></ul><p><strong>Histidine's Role in Hemoglobin:</strong></p><ul><li><strong>Hemoglobin</strong> contains a high number of histidine residues in its structure, particularly in the vicinity of the heme group.</li><li>These histidine residues are crucial for two key functions related to gas transport:<ul><li><strong>Proximal Histidine:</strong> Binds the heme iron to the globin chain.</li><li><strong>Distal Histidine:</strong> Helps stabilize the bound oxygen and prevents the oxidation of heme iron.</li></ul></li></ul><p><strong>Buffering and CO&#8322; Transport:</strong></p><ul><li>A significant portion of carbon dioxide (CO&#8322;) produced by tissues is transported in the blood bound to the <strong>N-terminal amino groups of hemoglobin's globin chains</strong>, forming <strong>carbaminohemoglobin</strong>.</li><li>The reaction is: <strong>Hb-NH&#8322; + CO&#8322; &#8652; Hb-NH-COOH</strong></li><li><strong>Histidine residues near the N-termini help buffer the protons (H&#8314;) released during this carbamate formation.</strong></li><li>In the tissues (lower pH), histidine residues are protonated, which stabilizes the deoxygenated (T) state of hemoglobin and facilitates the binding of CO&#8322; as carbamate.</li><li>In the lungs (higher pH), histidine loses a proton, which helps stabilize the oxygenated (R) state and promotes the release of CO&#8322;.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>To maintain the pH of urine </strong><strong>(Option A):</strong> This is primarily the function of the <strong>phosphate buffer system</strong> (HPO&#8324;&#178;&#8315;/H&#8322;PO&#8324;&#8315;) and the excretion of ammonium ions (NH&#8324;&#8314;) by the renal tubules.</p><p><strong>To facilitate enzymatic catalysis in the stomach </strong><strong>(Option B):</strong> The primary buffer in the stomach is not an amino acid within a protein; the extremely low pH is maintained by hydrochloric acid (HCl) secreted by parietal cells. The enzyme pepsin itself functions optimally in this acidic environment.</p><p><strong>To buffer lactic acid produced in skeletal muscle </strong><strong>(Option C):</strong> While intracellular proteins do provide some buffering capacity in muscle, the primary buffer for lactic acid in the blood is the <strong>bicarbonate buffer system</strong>(H&#8322;CO&#8323;/HCO&#8323;&#8315;). Hemoglobin's buffering action is more specifically tuned for the pH changes associated with gas exchange in the blood.</p><p><strong>Key Takeaways:</strong></p><ul><li>The buffering action of histidine in hemoglobin is integrated with the bicarbonate buffer system in what is known as the <strong>Chloride Shift</strong> or <strong>Hamburger phenomenon</strong>.</li><li>As hemoglobin releases oxygen and binds CO&#8322; and H&#8314; in the tissues, it enhances the blood's capacity to carry CO&#8322; as bicarbonate.</li></ul>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">A-chain of Insulin</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">B-chain of Insulin</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Proinsulin</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">C-Peptide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient is suspected of factitious hypoglycemia due to self-administration of insulin. To confirm exogenous insulin administration, a blood test is ordered that measures a polypeptide fragment released in equimolar amounts with endogenous insulin but is absent in pharmaceutical insulin preparations. This diagnostic test is based on the detection of which of the following?</span></p>",
      "unique_key": "Q319510",
      "question_audio": null,
      "question_video": null,
      "map_id": 319510,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Biosynthesis of Endogenous Insulin:</strong></p><ul><li>Insulin is synthesized in the pancreatic &beta;-cells as a single-chain precursor called <strong>preproinsulin</strong>.</li><li>This is quickly converted to <strong>proinsulin</strong>, which consists of the A-chain, B-chain, and the connecting <strong>C-peptide</strong>.</li><li>During packaging in secretory granules, proinsulin is cleaved by proteases to release:<ul><li><strong>Mature Insulin</strong> (A-chain and B-chain linked by disulfide bonds)</li><li><strong>C-Peptide</strong> (the connecting peptide)</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/23E.png\"><p><strong>Equimolar Release:</strong></p><ul><li>Endogenous insulin and C-peptide are stored together in secretory granules and are released into the bloodstream in <strong>equimolar amounts</strong> in response to a stimulus like glucose.</li></ul><p><strong>Clinical Application in Diagnosing Factitious Hypoglycemia:</strong></p><ul><li><strong>Pharmaceutical (Exogenous) Insulin:</strong> Commercial insulin preparations contain only the mature A and B chains. The C-peptide is <strong>not present</strong>.</li><li><strong>Diagnostic Logic:</strong> In a patient with hypoglycemia:<ul><li>If it is due to an endogenous insulinoma, both <strong>insulin and C-peptide levels will be high</strong>.</li><li>If it is due to self-administered (exogenous) insulin, <strong>insulin levels will be high, but C-peptide levels will be low or suppressed</strong> because the exogenous insulin suppresses endogenous &beta;-cell activity and no C-peptide is injected.</li></ul></li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>A-chain of Insulin </strong><strong>(Option A) &amp; B-chain of Insulin (Option B):</strong> These are the components of mature insulin and are present in both endogenous and exogenous (pharmaceutical) insulin. Therefore, they cannot differentiate between the two sources.</p><p><strong>Proinsulin </strong><strong>(Option C):</strong> This is the precursor molecule and is cleaved before secretion. Only very small amounts of intact proinsulin are released into the circulation under normal conditions. Its measurement is not the standard test for distinguishing endogenous from exogenous insulin; C-peptide is the gold standard.</p><p><strong>Key Takeaways:</strong></p><p>This is a crucial diagnostic tool to:</p><ul><li>Differentiate between Type 1 and Type 2 diabetes (C-peptide is low in T1DM).</li><li>Identify factitious hypoglycemia from exogenous insulin use.</li><li>Assess residual &beta;-cell function after pancreatic surgery or transplantation.</li></ul>",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamoyl Phosphate Synthetase I (CPS I)</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Ornithine Transcarbamylase (OTC)</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Argininosuccinate Synthetase</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Arginase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A newborn presents with lethargy, vomiting, and hyperammonemia. Urinalysis reveals markedly elevated orotic acid. This specific finding is pathognomonic for a deficiency in which urea cycle enzyme?</span></p>",
      "unique_key": "Q319511",
      "question_audio": null,
      "question_video": null,
      "map_id": 319511,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical and biochemical profile is classic for <strong>Ornithine Transcarbamylase (OTC) Deficiency</strong>, the most common urea cycle disorder, which is X-linked.</p><p><strong>Analysis of Clinical Features:</strong></p><ul><li><strong>Onset after 24 hours:</strong> The baby appears normal initially until protein feeding begins, leading to ammonia accumulation.</li><li><strong>Lethargy and Vomiting:</strong> Signs of hyperammonemic encephalopathy.</li><li><strong>Respiratory Alkalosis:</strong> A key early sign. Ammonia is a potent stimulant of the central respiratory center, leading to hyperventilation and a drop in PCO&#8322;.</li></ul><p><strong>Biochemical Basis and Metabolite Analysis:</strong></p><ul><li><strong>Enzyme Defect:</strong> OTC catalyzes the reaction: <strong>Carbamoyl Phosphate + Ornithine &rarr; Citrulline</strong></li><li><strong>Consequence of OTC Block:</strong><ul><li><strong>Accumulated Metabolite (Upstream):</strong> Carbamoyl phosphate accumulates in the mitochondria.</li><li><strong>Metabolite Shunt:</strong> The excess carbamoyl phosphate diffuses into the cytoplasm and enters the <strong>pyrimidine synthesis pathway</strong>.</li><li><strong>Orotic Aciduria:</strong> In the cytoplasm, carbamoyl phosphate combines with aspartate to form carbamoyl aspartate, which is then converted to <strong>orotic acid</strong>. This leads to its massive overproduction and excretion in urine, which is a <strong>diagnostic hallmark</strong>of OTC deficiency.</li></ul></li><li><strong>Elevated Amino Acid:</strong> The amino acid <strong>glutamine</strong> is always elevated in hyperammonemia as it is the primary nitrogen storage molecule. In OTC deficiency, <strong>alanine</strong> may also be elevated due to the ammonia-driven synthesis from pyruvate.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/24E.png\"><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Carbamoyl Phosphate Synthetase I (CPS I) (Option A):</strong> This is the first and rate-limiting enzyme of the urea cycle. Its deficiency also causes severe neonatal hyperammonemia. However, it does <strong>not</strong> cause orotic aciduria because the block is before the formation of carbamoyl phosphate. Without excess carbamoyl phosphate, there is no substrate to shunt into pyrimidine synthesis.</p><p><strong>Argininosuccinate Synthetase (Citrullinemia) (Option C):</strong> This enzyme combines citrulline with aspartate. Its deficiency leads to the massive accumulation of <strong>citrulline</strong> in the blood. Orotic acid levels are normal.</p><p><strong>Arginase (Argininemia) (Option D):</strong> This is the final enzyme of the cycle. Its deficiency causes accumulation of <strong>arginine</strong> and a milder, progressive form of hyperammonemia that presents later in infancy with spasticity and developmental delay, not a catastrophic neonatal crisis. Orotic acid is normal.</p><p><strong>Key Takeaways:</strong></p><ol><li><strong>NH&#8323; + CO&#8322; + 2ATP &rarr; Carbamoyl Phosphate</strong> (CPS I) [In Mitochondria]</li><li><strong>Carbamoyl Phosphate + Ornithine &rarr; Citrulline</strong> (OTC) [In Mitochondria]</li><li><strong>Citrulline + Aspartate &rarr; Argininosuccinate</strong> (Argininosuccinate Synthetase) [Requires ATP]</li><li><strong>Argininosuccinate &rarr; Arginine + Fumarate</strong> (Argininosuccinate Lyase)</li><li><strong>Arginine &rarr; Urea + Ornithine</strong> (Arginase)</li><li><strong>Disorder Clue: Orotic aciduria is pathognomonic for a block at OTC.</strong></li></ol>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate and Alanine</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Ammonia and Aspartate</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamine and Asparagine</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamoyl Phosphate and Ornithine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with chronic kidney disease (CKD) has a markedly elevated Blood Urea Nitrogen (BUN) level. Urea is the primary nitrogenous waste product in humans, synthesized in the liver via a cyclic metabolic pathway. The two nitrogen atoms found in a single molecule of urea are derived directly from which of the following pairs of compounds?</span></p>",
      "unique_key": "Q319512",
      "question_audio": null,
      "question_video": null,
      "map_id": 319512,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li>The urea cycle is the primary metabolic pathway for the detoxification and excretion of nitrogenous waste in humans.</li><li>Its main function is to convert highly toxic ammonia into water-soluble, non-toxic urea for excretion by the kidneys.</li><li>One molecule of urea contains <strong>two nitrogen atoms</strong>.</li></ul><p><strong>Source of the Two Nitrogen Atoms:</strong></p><ul><li><strong>First Nitrogen Atom:</strong> Enters the cycle as <strong>free ammonia (NHH&#8323;)</strong>. This ammonia is incorporated into <strong>Carbamoyl Phosphate</strong> in the first reaction of the cycle, catalyzed by Carbamoyl Phosphate Synthetase I (CPS I) in the mitochondria.</li><li><strong>Second Nitrogen Atom:</strong> Is contributed by the amino acid <strong>Aspartate</strong>. Aspartate donates its amino group in the reaction catalyzed by <strong>Argininosuccinate Synthetase</strong>, where it combines with Citrulline to form Argininosuccinate.</li></ul><p><strong>Fate of the Nitrogen Atoms:</strong></p><ul><li>These two nitrogen atoms are ultimately channeled into the amino acid <strong>Arginine</strong>.</li><li>The enzyme <strong>Arginase</strong> then hydrolyzes Arginine to yield <strong>Urea</strong> (which contains both nitrogen atoms) and <strong>Ornithine</strong>, which re-enters the cycle.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Glutamate and Alanine (Option A):</strong> While glutamate is a central molecule in transamination and ammonia transport (via glutamine synthesis), and alanine is important in the glucose-alanine cycle, they are not the direct donors of nitrogen to the urea molecule itself. They transfer their nitrogen to other intermediates like &alpha;-ketoglutarate (forming glutamate) or oxaloacetate (forming aspartate) first.</p><p><strong>Glutamine and Asparagine (Option C):</strong> Glutamine is a key nitrogen carrier and can donate its side-chain nitrogen to form carbamoyl phosphate via mitochondrial glutaminase. However, the question asks for the directdonors in the cyclic pathway. Asparagine is not a direct nitrogen donor to the urea cycle.</p><p><strong>Carbamoyl Phosphate and Ornithine (Option D):</strong> Carbamoyl phosphate contains the first nitrogen (from ammonia), but Ornithine is a carrier in the cycle and does not donate a nitrogen atom to urea. It is regenerated at the end of the cycle.</p><p><strong>Key Takeaways:</strong></p><p>The path of nitrogen from protein catabolism to excretion is:</p><p><strong>Dietary Protein &rarr; Amino Acids &rarr; Amino Groups (NH&#8322;) &rarr; Ammonia (NHH&#8323;) &rarr; Urea Cycle (in Liver) &rarr; Urea &rarr; Excretion (by Kidneys)</strong></p>",
      "correct_choice_id": 242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Fructose</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactose</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactose</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Sucrose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2-week-old neonate, recently started on breast milk, presents with vomiting, diarrhea, jaundice, and hepatomegaly. The pediatrician suspects an inborn error of metabolism. Initial urinalysis is positive for reducing substances but negative for glucose. This specific finding is most indicative of a defect in the metabolic pathway of which sugar?</span></p>",
      "unique_key": "Q319513",
      "question_audio": null,
      "question_video": null,
      "map_id": 319513,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical presentation is classic for <strong>Classic Galactosemia</strong>, most commonly caused by a deficiency of the enzyme <strong>Galactose-1-Phosphate Uridyltransferase (GALT)</strong>.</p><p><strong>Analysis of Urine Test Results:</strong></p><ul><li><strong>Positive Reducing Sugar Test:</strong> This test (e.g., Benedict's test) is positive for any sugar with a free aldehyde or ketone group, including glucose, galactose, and fructose.</li><li><strong>Negative Glucose Oxidase Test:</strong> This test is highly specific for glucose.</li><li>The discrepancy (reducing substances present but glucose absent) indicates the presence of a <strong>non-glucose reducing sugar</strong> in the urine. In a neonate on milk feeds, this is highly suggestive of <strong>galactosuria</strong> (galactose in urine).</li></ul><p><strong>Pathophysiology of Classic Galactosemia:</strong></p><ul><li>The primary defect is in the <strong>Leloir pathway</strong> of galactose metabolism.</li><li>The metabolic block at the GALT enzyme step leads to the toxic accumulation of:<ul><li><strong>Galactose-1-Phosphate (Gal-1-P):</strong> This is the primary toxic metabolite that causes cellular damage.</li><li><strong>Galactose:</strong> The upstream substrate that accumulates and spills into the urine and blood (galactosemia and galactosuria).</li></ul></li><li><strong>Galactitol:</strong> Excess galactose is also reduced to galactitol by aldose reductase. Galactitol accumulates in the lens of the eye, causing osmotic damage and <strong>cataracts</strong>.</li></ul><p><strong>Correlation of Clinical Features:</strong></p><ul><li><strong>Onset with Milk Feeds:</strong> Breast milk and formula contain lactose, which is a disaccharide of glucose and galactose.</li><li><strong>Vomiting and Diarrhea:</strong> Due to the toxic effects on the intestinal mucosa and liver.</li><li><strong>Jaundice and Hepatomegaly:</strong> Caused by the accumulation of Gal-1-P in hepatocytes, leading to liver damage and impaired bilirubin conjugation.</li><li>If untreated, the condition can progress to <strong> coli sepsis</strong> (due to impaired neutrophil function), intellectual disability, and cataracts.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Fructose (Option A):</strong> A defect in fructose metabolism (Hereditary Fructose Intolerance) also causes vomiting and liver damage, but symptoms are triggered only by the introduction of fructose/sucrose in the diet, not by breast milk alone. It does not typically cause a positive reducing sugar in urine.</p><p><strong>Lactose (Option C):</strong> Lactose intolerance is due to a deficiency of lactase in the intestinal brush border. It causes diarrhea and bloating but not the systemic, life-threatening symptoms like jaundice, hepatomegaly, or cataracts seen here. It does not cause a positive urinary reducing substance.</p><p><strong>Sucrose (Option D):</strong> Sucrose is a non-reducing sugar and would not cause a positive reducing sugar test. There is no common \"sucrosemia\" disorder.</p><p><strong>Key Takeaways:</strong></p><p>The goal is to convert Galactose to Glucose-1-Phosphate.</p><ol><li>Galactose &rarr; Galactose-1-P (Galactokinase)</li><li>Galactose-1-P + UDP-Glucose &rarr; Glucose-1-P + UDP-Galactose (<strong>Galactose-1-P Uridyltransferase - Deficient in Classic Galactosemia</strong>)</li><li>UDP-Galactose &rarr; UDP-Glucose (UDP-Galactose-4-Epimerase)</li></ol><p><strong>A positive urinary reducing substance in a sick neonate that is non-glucose is galactosemia until proven otherwise.</strong></p>",
      "correct_choice_id": 252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">GLUT-1</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">GLUT-2</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">GLUT-3</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">GLUT-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man with type 2 diabetes mellitus has a fasting blood glucose of 160 mg/dL. His treatment includes a drug that inhibits the sodium-glucose cotransporter 2 (SGLT2) in the kidney, leading to glucosuria. However, the facilitated diffusion of glucose from his blood into his skeletal muscle and adipose tissue for metabolism is unaffected by this drug. This insulin-sensitive glucose uptake into muscle and adipose tissue is primarily mediated by which of the following transporters?</span></p>",
      "unique_key": "Q319514",
      "question_audio": null,
      "question_video": null,
      "map_id": 319514,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li><strong>GLUT-4</strong> is the <strong>insulin-regulated glucose transporter</strong>.</li><li>It is primarily expressed in <strong>insulin-sensitive tissues</strong>: <strong>Skeletal muscle</strong>, <strong>cardiac muscle</strong>, and <strong>adipose tissue</strong>.</li></ul><p><strong>Mechanism of Action:</strong></p><ul><li>In the basal (fasting) state, most GLUT-4 transporters are stored in intracellular vesicles within the cytoplasm.</li><li>When insulin levels rise after a meal, it binds to its receptor on the surface of muscle and fat cells.</li><li>This triggers a signaling cascade that causes these intracellular vesicles containing GLUT-4 to translocate and fuse with the plasma membrane.</li><li>This dramatically increases the number of GLUT-4 transporters on the cell surface, thereby <strong>facilitating the uptake of glucose</strong> from the blood into these tissues.</li><li>This mechanism is crucial for postprandial clearance of blood glucose.</li></ul><p><strong>Clinical Correlation:</strong></p><ul><li><strong>Insulin Resistance,</strong> a hallmark of Type 2 Diabetes Mellitus, is characterized by a blunted response to insulin, leading to impaired GLUT-4 translocation and subsequent reduced glucose uptake into muscle and adipose tissue. This contributes to persistent hyperglycemia.</li><li>The question correctly states that SGLT2 inhibitors act on a different, active transport system in the kidney and do not affect the facilitated diffusion mediated by GLUT transporters in peripheral tissues.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>GLUT-1 (Option A):</strong> This is a ubiquitous transporter responsible for <strong>basal glucose uptake</strong> in most cells, including erythrocytes and the blood-brain barrier. It is <strong>not regulated by insulin</strong>.</p><p><strong>GLUT-2 (Option B):</strong> This is a low-affinity, high-capacity transporter found in <strong>hepatocytes</strong>, <strong>pancreatic &beta;-cells</strong>, and the <strong>renal tubules</strong> and intestinal epithelium. It acts as a glucose sensor in &beta;-cells and is involved in bidirectional glucose transport in the liver. It is <strong>not insulin-sensitive</strong>.</p><p><strong>GLUT-3 (Option C):</strong> This is the primary glucose transporter in <strong>neurons</strong>. It has a high affinity for glucose, ensuring a constant supply to the brain even during hypoglycemia. It is <strong>not regulated by insulin</strong>.</p><p><strong>Key Takeaways: Major GLUT Transporters and Their Roles</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/27E.png\">",
      "correct_choice_id": 264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Acid alpha-glucosidase (Acid maltase)</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver glycogen phosphorylase</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle glycogen phosphorylase</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Debranching enzyme</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old man presents with a history of exercise intolerance, experiencing muscle cramps and pain within the first few minutes of vigorous activity. He reports that his symptoms improve if he rests briefly after the initialpain, a phenomenon he calls a \"second wind.\" A forearm ischemic exercise test is performed, which shows no rise in venous lactate levels. This presentation is most characteristic of a deficiency in which of the following enzymes?</span></p>",
      "unique_key": "Q319515",
      "question_audio": null,
      "question_video": null,
      "map_id": 319515,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical presentation is classic for <strong>McArdle Disease (Glycogen Storage Disease Type V)</strong>.</p><p><strong>Defective Enzyme and Metabolic Block:</strong></p><ul><li>McArdle disease is caused by a deficiency of <strong>muscle glycogen phosphorylase</strong>.</li><li>This enzyme catalyzes the rate-limiting step in glycogenolysis: the cleavage of glucose-1-phosphate from glycogen.</li><li>The block is specific to <strong>skeletal muscle</strong>, as a different isoenzyme (liver glycogen phosphorylase) functions in the liver.</li></ul><p><strong>Pathophysiology of Symptoms:</strong></p><ul><li><strong>Exercise Intolerance &amp; Cramps (First 5-10 minutes):</strong> During initial intense exercise, muscles rely heavily on anaerobic glycogenolysis for rapid ATP production. The enzyme deficiency prevents this, leading to an <strong>energy crisis</strong>, muscle ischemia, and pain.</li><li><strong>The \"Second Wind\" Phenomenon:</strong> After resting briefly, the patient can often continue exercise at a moderate pace. This occurs because the body shifts to using <strong>bloodborne fuels</strong> (glucose from the liver and free fatty acids) that do not require muscle glycogenolysis. The liver glycogenolysis pathway is intact.</li><li><strong>No Rise in Venous Lactate (Forearm Ischemic Exercise Test):</strong> This is a <strong>diagnostic hallmark</strong>. Normally, anaerobic glycogenolysis produces pyruvate, which is converted to lactate, causing a rise in venous lactate levels. In McArdle disease, the block in glycogenolysis prevents lactate production, so levels do not increase. This test is highly specific for a defect in glycogen breakdown in muscle.</li></ul><p><strong>Clinical Correlation:</strong></p><ul><li>Patients may also exhibit <strong>myoglobinuria</strong> (dark urine) following severe episodes of muscle breakdown (rhabdomyolysis).</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Acid alpha-glucosidase (Pompe disease, Type II) (Option A):</strong> This is a <strong>lysosomal</strong> storage disease affecting all tissues, but primarily causing <strong>cardiomegaly</strong>, <strong>hypotonia</strong>, and respiratory failure, not isolated exercise-induced cramps. It does not present with a \"second wind\" phenomenon.</p><p><strong>Liver glycogen phosphorylase (Hers disease, Type VI) (Option B):</strong> This deficiency causes <strong>hepatomegaly</strong> and <strong>fasting hypoglycemia</strong>, not exercise-induced muscle cramps. The glycemic response to glucagon is normal.</p><p><strong>Debranching enzyme (Cori disease, Type III) (Option D):</strong> This causes hepatomegaly, hypoglycemia, and a <strong>progressive myopathy</strong>, but not the specific acute exercise intolerance with cramps and the \"second wind\" phenomenon. The forearm exercise test would show a blunted, not absent, lactate rise.</p><p><strong>Key Takeaways:</strong></p><ul><li><strong>First few minutes:</strong> Relies on stored <strong>muscle glycogen</strong> (blocked in McArdle's).</li><li><strong>After \"second wind\":</strong> Relies on <strong>blood glucose</strong> (from liver glycogen) and <strong>free fatty acids</strong>.</li></ul>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose and Fructose</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose and Galactose</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Two Glucose molecules</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactose and Fructose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-month-old infant presents with failure to thrive, vomiting, and jaundice. The parents report that the child develops symptoms after milk feeds. Urine tests positive for a reducing sugar but is negative on the glucose oxidase strip. The pediatrician suspects a defect in the metabolism of a specific disaccharide. The disaccharide in question is composed of which two monosaccharides?</span></p>",
      "unique_key": "Q319516",
      "question_audio": null,
      "question_video": null,
      "map_id": 319516,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical presentation is highly suggestive of <strong>Galactosemia</strong>, an inborn error of metabolism affecting the disaccharide derived from milk.</p><p><strong>Identifying the Disaccharide from the Clinical Clue:</strong></p><ul><li>The trigger is <strong>milk feeds</strong>. The major carbohydrate in milk is the disaccharide <strong>Lactose</strong>.</li><li>Lactose is hydrolyzed in the small intestine to its component monosaccharides: <strong>Glucose and Galactose</strong>.</li></ul><p><strong>Pathophysiology of Galactosemia:</strong></p><ul><li>In Classic Galactosemia (often due to Galactose-1-Phosphate Uridyltransferase deficiency), the infant cannot metabolize the <strong>Galactose</strong> moiety derived from lactose.</li><li>This leads to the toxic accumulation of metabolites like galactose-1-phosphate and galactitol, causing liver damage (jaundice, hepatomegaly), renal tubular dysfunction, and cataracts.</li></ul><p><strong>Analysis of Urine Test Results:</strong></p><ul><li><strong>Positive Reducing Sugar:</strong> Both glucose and galactose are reducing sugars. The accumulated galactose is excreted in the urine (galactosuria).</li><li><strong>Negative Glucose Oxidase Test:</strong> This test is specific for glucose. The negative result confirms that the reducing sugar in the urine is <strong>not glucose</strong>, pointing strongly towards <strong>galactose</strong>. This finding, in a sick infant on milk feeds, is pathognomonic for galactosemia.</li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Glucose and Fructose </strong><strong>(Option A):</strong> This is the composition of <strong>Sucrose</strong> (table sugar). A defect in sucrose metabolism (sucrase-isomaltase deficiency) causes osmotic diarrhea but not the systemic, life-threatening symptoms of liver failure and cataracts seen in this infant.</p><p><strong>Two Glucose molecules </strong><strong>(Option C):</strong> This describes <strong>Maltose</strong> (and Isomaltose), which are products of starch digestion. Malabsorption does not cause this specific clinical picture.</p><p><strong>Galactose and Fructose </strong><strong>(Option D):</strong> This combination does not form a common, naturally occurring disaccharide.</p><p><strong>Key Takeaways: Source and Fate of Dietary Disaccharides</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTII09102025/29E.png\"><ul><li>A positive urinary reducing substance in a sick neonate that is non-glucose is highly indicative of <strong>Galactosemia</strong>.</li></ul>",
      "correct_choice_id": 282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycolysis</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Urea Cycle</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Pentose Phosphate Pathway</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta-Oxidation of Fatty Acids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old boy of Mediterranean descent is brought to the emergency department with dark brown urine and jaundice 48 hours after being started on an antibiotic for a febrile illness. Peripheral smear shows bite cells and Heinz bodies. This hemolytic crisis is most likely triggered by a defect in which of the following metabolic pathways, leading to impaired protection against oxidative stress?</span></p>",
      "unique_key": "Q319517",
      "question_audio": null,
      "question_video": null,
      "map_id": 319517,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical presentation is a classic acute hemolytic anemia due to <strong>Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency</strong>.</p><p><strong>Defective Enzyme and Pathway:</strong></p><ul><li>The defect is in the enzyme <strong>Glucose-6-Phosphate Dehydrogenase (G6PD)</strong>, which catalyzes the first and rate-limiting step of the <strong>Pentose Phosphate Pathway (PPP)</strong>or Hexose Monophosphate (HMP) Shunt.</li><li>Reaction: Glucose-6-Phosphate + NADP&#8314; &rarr; 6-Phosphoglucono-&delta;-lactone + <strong>NADPH + H&#8314;</strong></li></ul><p><strong>Role of the Pathway in Red Blood Cells (RBCs):</strong></p><ul><li>The primary role of the PPP in RBCs is <strong>not</strong> to produce pentose sugars, but to generate <strong>NADPH</strong>.</li><li><strong>NADPH</strong> is essential for maintaining <strong>reduced glutathione (GSH)</strong> in the cell via the enzyme glutathione reductase.</li><li><strong>Reduced Glutathione (GSH)</strong> is a crucial antioxidant that protects hemoglobin and RBC membrane proteins from oxidative damage by neutralizing reactive oxygen species (ROS).</li></ul><p><strong>Pathophysiology of Hemolytic Crisis:</strong></p><ul><li>In G6PD deficiency, the inability to generate sufficient NADPH leads to <strong>depleted levels of reduced glutathione (GSH)</strong>.</li><li>When exposed to <strong>oxidative stress</strong> (from drugs like primaquine, sulfonamides, infections, or fava beans), the RBC cannot effectively neutralize the ROS.</li><li>This causes:<ul><li><strong>Oxidation of Hemoglobin:</strong> Leads to denaturation and precipitation as <strong>Heinz bodies</strong> (visible with special staining).</li><li><strong>Membrane Damage:</strong> As Heinz bodies are removed by splenic macrophages, they pinch out parts of the RBC membrane, forming <strong>\"bite cells\"</strong>.</li><li><strong>Intravascular Hemolysis:</strong> The damaged RBCs lyse, releasing hemoglobin, which is metabolized to bilirubin (causing <strong>jaundice</strong>) and excreted as hemosiderin, leading to <strong>dark brown urine</strong>.</li></ul></li></ul><p><strong>Explanation of Incorrect options:</strong></p><p><strong>Glycolysis (Option A):</strong> Defects in glycolysis (e.g., Pyruvate Kinase deficiency) also cause hemolytic anemia, but the mechanism is due to ATP depletion, not oxidative damage. Heinz bodies and bite cells are not characteristic findings.</p><p><strong>Urea Cycle (Option B):</strong> This cycle is for ammonia detoxification in the liver. Its defects cause hyperammonemia and neurological symptoms, not hemolytic anemia.</p><p><strong>Beta-Oxidation of Fatty Acids (Option D):</strong> Defects here cause metabolic crises with hypoglycemia and hepatic encephalopathy, typically triggered by fasting, not by oxidative drugs.</p><p><strong>Key Takeaways: The Antioxidant Defense in RBCs</strong></p><p><strong>Pentose Phosphate Pathway &rarr; NADPH &rarr; Reduced Glutathione (GSH) &rarr; Protection from Oxidative Damage</strong></p><p><strong>Common Triggers for Hemolysis in G6PD Deficiency:</strong></p><ul><li><strong>Drugs:</strong> Antimalarials (Primaquine), Sulfonamides, Nitrofurantoin</li><li><strong>Infections</strong></li><li><strong>Fava Beans</strong> (Favism)</li></ul>",
      "correct_choice_id": 293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}